Is dual defibrillator better than conventional DDD pacing in brady-tachy syndrome? Results of the ICARUS trial (Internal Cardioversion Antitachy Pacing and Prevention: Resource Utilization Study)

Journal of Interventional Cardiac Electrophysiology

Volumn 14, Issue 3, 2005, Pages 159-168

  Santini, Massimo ^a   Ricci, Renato ^a   Pignalberi, Carlo ^a   Russo, Maurizio ^a   Magris, Barbara ^a   Grovale, Nicoletta ^a   De Santo, Tiziana ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

Atrial fibrillation; Brady tachy syndrome; Dual chamber pacing; Dual defibrillator

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HEART PACING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RECURRENT DISEASE; SHOCK; SHORT FORM 36; SINUS NODE DISEASE; SYMPTOM CHECKLIST 90;

AGED; ATRIAL FIBRILLATION; BRADYCARDIA; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; STATISTICS, NONPARAMETRIC; SYNDROME; TACHYCARDIA;

EID: 31144452491     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-006-6204-3     Document Type: Article

References (42)

1. Sutton R, Kenny RA. The natural history of sick sinus syndrome. PACE 1986;9:1110-1114.
2. Camm AJ, Katritsis D. Ventricular pacing for sick sinus syndrome: A risky business? PACE 1990;13:695-699.
3. Santini M, Alexidou G, Ansalone G, Cacciatore G, Cini R, Turitto G. Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing. Am J Cardiol 1990;65:729-735.
4. Stangl K, Seitz K, Wirtzfeld A, Alt E, Blommer H. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome. PACE 1990;13:2080-2085.
5. Feuer JM, Shandling AH, Messenger JC. Influence of cardiac pacing mode on the long-term development of atrial fibrillation. Am J Cardiol 1989;64:1376-1379.
6. Rosenqvist M, Brandt J, Schuller H. Long-term pacing in sinus node disease: Effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988;116:16-22.
7. Hesselson AB, Parsonnet V, Bernstein AD, Bonavita GJ. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: The hidden benefits of dual-chamber pacing. J Am Coll Cardiol 1992;19:1542-1549.
8. Sgarbossa EB, Pinski SL, Maloney JD, Simmons TW, Wilkoff BL, Castle LW, Trohman RG. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. Circulation 1993;88:1045-1053.
9. Santini M, Ricci R, Puglisi A, Mangiameli S, Proclemer A, Menozzi C, De Fabrizio G, Leoni G, Lisi F, de Seta F. Long-term haemodynamic and antiarrhythmic benefits of DDIR versus DDI pacing mode in sick sinus syndrome and chronotropic incompetence. G Ital Cardiol 1997;27:892-900.
10. Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK. Long-term follow up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-1216.
11. Mattioli AV, Vivoli D, Mattioli G. Influence of pacing modalities on the incidence of atrial fibrillation in patients without prior atrial fibrillation: A prospective study. Eur Heart J 1998;19:282-286.
12. Skanes AC, Krahn AD, Yee R, Klein GJ, Connolly SJ, Kerr CR, Gent M, Thorpe KE, Roberts RS for the CTOPP Investigators: Progression to chronic atrial fibrillation after pacing: The Canadian Trial of Physiologic Pacing. J Am Coll Cardiol 2001;38:167-172.
13. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G, Schron E, Orav EJ, Hellkamp AS, Goldman L, for the Mode Selection Trial in Sinus Node Dysfunction. Ventricular pacing or dual chamber pacing for sinus node dysfunction. N Engl J Med 2002;346:1854-1862.
14. Ricci R, Santini M, Puglisi A, Azzolini P, Capucci A, Pignalberi C, Boriani G, Botto GL, Spampinato A, Bellocci F, Proclemer A, Grammatico A, de Seta F. Impact of consistent atrial pacing algorithm on premature atrial complexe number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: A randomized prospective cross over study. J Interv Card Electrophysiol 2001;5:33-44.
15. Friedman PA, Dijkman B, Warman EN, Xia HA, Mehra R, Stanton MS, Hamill SC, for the Worldwide Jewel AF Investigators. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 2001;104:1023-1028.
16. Ricci R, Pignalberi C, Disertori M, Capucci A, Padeletti L, Botto G, Boriani G, Miraglia F, de Santo T, Santini M. Antitachycardia pacing therapy to treat spontaneous atrial tachyarrhythmias: The 7250 Dual Defibrillator Italian Registry. Eur Heart J 2001;3(Suppl. P):P25-P32.
17. Wellens HJJ, Lau CP, Luderitz B, Akhtar M, Waldo AL, Camm AJ, Timmermans C, Tse HF, Jung W, Jordaens L, Ayers G. Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 1998;98:1651-1656.
18. Gold MR, Sulke N, Schwartzman DS, Mehra R, Euler DE, for the Worldwide Jewel AF-Only Investigators: Clinical experience with a dual chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 2001;12:1247-1253.
19. Ricci R, Pignalberi C, Disertori M, Capucci A, Padeletti L, Botto G, Toscano S, Miraglia F, Grammatico A, Santini M. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J 2002;23:1471-1479.
20. Adler SW, Wolpert C, Warman EN, Musley SK, Koehler JL, Euler DE for the Worldwide Jewel AF Investigators. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 2001;104:887-892.
21. Wijffels MCEF, Kirchhof CJHJ, Borland RD, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
22. Savelieva I, Camm J. The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: Is there any evidence of therapeutic breakthrough? J Interv Cardiac Electrophysiol 2003;8:103-115.
23. Jenkins LS, Bubien RS. Quality of life in patients with atrial fibrillation. Cardiol. Clin. 1996;14:597-606.
24. Ware JE. The SF-36 health survey manual and interpretation guide. Boston, MA, The Health Institute, New England Medical Center; 1993.
25. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 1992;30:473-483.
26. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health conditions. Med. Care 1993;81:247-263.
27. McHorney CA, Ware JE, Lu JFR, Sherbourne CD. The MOS 36-item short-form health (SF-36), III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med. Care 1994;82:40-66.
28. Bubien RS, Kay GN, Jenkins LS. Test specifications for symptom checklist. Frequency and severity. 1993. Milwaukee, University of Wisconsin-Milwaukee.
29. Tanigawa M, Fukatani M, Konoe A, Isomoto S, Kadena M, Hashiba K. Prolonged and fractionated atrial electrograms during sinus rhythm in patients with paroxismal atrial fibrillation and sick sinus node syndrome. J Am Coll Cardiol 1991;17:403-408.
30. Centurion OA, Fukatani M, Konoe A, Tanigawa M, Shimizu A, Isomoto S, Kaibara M, Hashiba K. Different distribution of abnormal endocardial electrograms within the right atrium in patients with sick sinus syndrome. Br Heart J 1992;68:596-600.
31. De Sisti A, Leclercq JF, Fiorello P, Manot S, Halimi F, Attuel P. Electrophysiologic characteristics of the atrium in sinus node dysfunction: Atrial refractoriness and conduction. J Cardiovasc Electrophysiol 2000;11:30-33.
32. De Sisti A, Attuel P, Manot S, Fiorello P, Halimi F, Leclercq JF. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing. Europace 2000;2:304-311.
33. Stabile G, Senatore G, De Simone A, Turco P, Coltorti F, Nocerino P, Vitale DF, Chiariello M. Determinants of efficacy of atrial pacing in preventing atrial fibrillation recurrences. J Cardiovasc Electrophysiol 1999;10:2-9.
34. Timmermans C, Levy S, Ayers GM, for the Metrix Investigators. Spontaneous episodes of atrial fibrillation after implantation of the Metrix atrioverter: Observations on treated and nontreated episodes. J Am Coll Cardiol 2000;35:1428-1433.
35. Tse HF, Lau CP, Yu CM, Lee KL, Michaud GF, Knight GP, Morady F, Strickberger SA. Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:1200-1209.
36. Ricci R, Quesada A, Pignalberi C, Roda J, Disertori M, Capucci A, Raviele A, Santini M. Dual defibrillator improves quality of life and decreases hospitalizations in patients with drug refractory atrial fibrillation. J Interv Card Electrophysiol 2004;10:85-92.
37. Jung W, Luderitz B. Quality of life in patients with atrial fibrillation. J Cardiovasc Electrophysiol 1998;9(Suppl.8):S177-S186.
38. Herrmann C, vonzurMuhen F, Schaumann A, Buss U, Kemper S, Wantzen C, Gonska BD. Standardized assessment of psychological well-being and quality-of-life in patients with implanted defibrillators. Pacing Clin Electrophysiol 1997;20:95-103.
39. Padeletti L, Santini M, Boriani G, Botto GL, Capucci A, Gulizia M, Ricci R, Spampinato A, Pieragnoli P, Warman E, Vimercati M, Grammatico A. Temporal variability of atrial tachyarrhythmia burden in bradycardiatachycardia syndrome patients. Eur Heart J 2005;26:165-172.
40. Padeletti L, Pieragnoli P, Ciapetti C, Colella A, Musilli N, Porciani MC, Ricci R, Pignalberi C, Santini M, Puglisi A, Azzolini P, Spampinato A, Martelli M, Capucci A, Boriani G, Botto G, Proclemer A. Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 2001;142:1047-1055.
41. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA. for the Mode Selection Trial (MOST) Investigators: Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-2937.
42. Boodhoo L, Mitchell A, Ujhelyi M, Sulke N. Improving the acceptability of the atrial defibrillator: Patient-activated cardioversion versus automatic night cardioversion with and without sedation (ADSAS 2). Pacing Clin Electrophysiol 2004;27:910-917.